Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Marlin Equity Partners Closes €675 Million For Second Europe Fund

Marlin Equity Partners, a leading global investment firm, is pleased to announce the final closing of Marlin Heritage Europe II, L.P., with €675 million of total capital commitments, more than double the size of its predecessor fund. The Fund successfully closed over its target with strong support from existing limited partners and significant interest from new global investors.

Heritage Europe II is a continuation of the investment strategy employed by Marlin for over 15 years and by its predecessor fund, Marlin Heritage Europe, L.P. The Fund will apply the same philosophy and process-driven approach to investing utilized by prior Marlin funds and will target investments in middle-market companies generally located in Europe, where the firm has been active since 2006 and formally established a London office in 2012. Consistent with Marlin’s historical focus, Heritage Europe II will seek to invest in sustainable, high potential companies that can benefit from the firm’s rich history of accelerating growth and scaling businesses, as well as its substantial operational resources. The Fund will continue to focus on industries where Marlin has developed extensive domain expertise, including software, technology, healthcare and tech-enabled business and financial services.

Recommended AI News: Fullstack Academy and Cleveland State University Partner to Bring Accelerated Tech Skills Training to Ohio

“Our ability to successfully raise more than twice the amount of capital of the prior fund further validates our standing and recognition as a leading firm in the region and value-add partner,” said David McGovern, Founder, Chairman and Chief Executive Officer of Marlin. “We are thankful for the support from our existing investor base and newest partners, and now look forward to continuing to execute our operationally-focused investment strategy to help companies build long-term value and deliver successful outcomes for our partners.”

Related Posts
1 of 40,490

Peter Spasov, Senior Managing Director of Marlin, added, “Our success in Europe is a result of our deep domain expertise across the industries we target, demonstrated investment experience in the region, established global infrastructure and collaborative approach to working alongside management teams to affect growth-oriented, value-enhancing initiatives. We are excited to continue to capitalize on the rapid digital transformation occurring broadly across businesses and industries today, and firmly believe we are uniquely positioned to help companies accelerate their business models in the ongoing digitization wave.”

Recommended AI News: Artur’In Secures €42 Million in Funding from PSG to Accelerate Growth

Marlin has closed 9 private equity funds and completed over 180 acquisitions since its inception in 2005, and has more than $7.6 billion of capital under management. The closing of Heritage Europe II follows a period of strong investment activity for the firm. Since the beginning of 2020, and amidst the global pandemic backdrop, Marlin has acquired 26 businesses and completed 8 exits.

Sarah RobertsKatie St. PetersKarin Orsic and Bruce Ettelson of Kirkland & Ellis LLP served as legal counsel and Credit Suisse Securities (USA), LLC acted as exclusive private placement advisor and placement agent in the formation of Heritage Europe II.

Recommended AI News: Etiometry Raises $9 Million in Series A-3 Funding to Fuel Business and Leadership Team Expansion, R&D Acceleration, and Clinical Initiatives

Comments are closed.